Clive Morris
Keine laufenden Positionen mehr
Karriereverlauf von Clive Morris
Ehemalige bekannte Positionen von Clive Morris
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Inivata Ltd.
 Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 01.05.2016 | 30.06.2022 |
| Vorstandsvorsitzender | 01.07.2018 | 18.06.2021 | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.05.2016 | 01.07.2018 | |
| Präsident | 18.06.2021 | 23.05.2022 | |
| NEOGENOMICS, INC. | Corporate Officer/Principal | - | 30.06.2022 |
| CorpHQ, Inc. | Corporate Officer/Principal | - | 06.08.2007 |
| ASTRAZENECA PLC | Public Communications Contact | 06.01.2011 | - |
Ausbildung von Clive Morris
| The Royal College of Surgeons of England | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
| Vereinigte Staaten | 3 |
Operativ
| Corporate Officer/Principal | 2 |
| Public Communications Contact | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Health Services | 2 |
| Communications | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| NEOGENOMICS, INC. | Health Services |
| Private Unternehmen | 2 |
|---|---|
| CorpHQ, Inc. | Communications |
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Börse
- Insiders
- Clive Morris
- Erfahrung
